DAVID M. TANEN - 22 Jun 2021 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Director
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
22 Jun 2021
Net transactions value
$0
Form type
4
Filing time
23 Jun 2021, 21:12:21 UTC
Next filing
29 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Stock Option (Right to Buy) Award $0 +20,600 $0.000000 20,600 22 Jun 2021 Common Stock 20,600 $24.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.